• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙酰氧肟酸治疗鸟粪石性肾结石的随机双盲研究。

A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis.

作者信息

Williams J J, Rodman J S, Peterson C M

出版信息

N Engl J Med. 1984 Sep 20;311(12):760-4. doi: 10.1056/NEJM198409203111203.

DOI:10.1056/NEJM198409203111203
PMID:6472365
Abstract

We studied the effects of the bacterial urease inhibitor acetohydroxamic acid on the growth of struvite stones in the urinary tract. Eighteen patients who received acetohydroxamic acid (15 mg per kilogram of body weight per day, in divided oral doses) for a mean of 15.8 months were compared in a randomized double-blind study with 19 patients who received placebo for a mean of 19.6 months. Seven patients given placebo reached a pre-determined end point: a 100 per cent increase in the two-dimensional surface area of their stones. No patient who received acetohydroxamic acid had a doubling of stone size (P less than 0.01). Nine patients receiving the drug and one patient receiving placebo required a decrease in dosage or cessation of treatment because of adverse effects (P less than 0.01). Episodes of tremulousness (n = 5, P less than 0.05), which reversed with a decrease in drug dose, and phlebothrombosis (n = 3, P not significant) were limited to the group given acetohydroxamic acid. We conclude that acetohydroxamic acid effectively inhibits the growth of struvite stones in the short term in patients infected with urea-splitting bacteria, but the prevalence of adverse reactions appears to be high and the toxicity and effectiveness of long-term therapy for struvite nephrolithiasis remain to be defined.

摘要

我们研究了细菌脲酶抑制剂乙酰氧肟酸对尿路中鸟粪石结石生长的影响。在一项随机双盲研究中,将18例平均服用乙酰氧肟酸(每日每千克体重15毫克,分口服剂量)15.8个月的患者与19例平均服用安慰剂19.6个月的患者进行了比较。7例服用安慰剂的患者达到了预定终点:结石二维表面积增加100%。接受乙酰氧肟酸治疗的患者中,没有一例结石大小翻倍(P<0.01)。9例接受该药物治疗的患者和1例接受安慰剂治疗的患者因不良反应需要减少剂量或停止治疗(P<0.01)。震颤发作(n=5,P<0.05)在减少药物剂量后逆转,静脉血栓形成(n=3,P无显著性差异)仅限于服用乙酰氧肟酸的组。我们得出结论,乙酰氧肟酸在短期内可有效抑制感染尿素分解菌患者的鸟粪石结石生长,但不良反应的发生率似乎较高,鸟粪石肾结石长期治疗的毒性和有效性仍有待确定。

相似文献

1
A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis.乙酰氧肟酸治疗鸟粪石性肾结石的随机双盲研究。
N Engl J Med. 1984 Sep 20;311(12):760-4. doi: 10.1056/NEJM198409203111203.
2
Partial dissolution of struvite calculus with oral acetohydroxamic acid.口服乙酰氧肟酸使鸟粪石结石部分溶解。
Urology. 1983 Oct;22(4):410-2. doi: 10.1016/0090-4295(83)90424-7.
3
[Treatment of infectious renal lithiasis with acetohydroxamic acid].用乙酰氧肟酸治疗感染性肾结石
Arch Esp Urol. 1983 Sep-Oct;36(5):354-62.
4
Acetohydroxamate in struvite stones: in vivo study.
Proc Eur Dial Transplant Assoc. 1983;20:469-72.
5
New drug therapy for kidney stones: a review of cellulose sodium phosphate, acetohydroxamic acid, and potassium citrate.肾结石的新药治疗:对磷酸纤维素钠、乙酰氧肟酸和柠檬酸钾的综述
Drug Intell Clin Pharm. 1985 Jul-Aug;19(7-8):530-9. doi: 10.1177/106002808501900705.
6
A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal cord injury patients.一项关于乙酰氧肟酸治疗和预防脊髓损伤患者感染性尿路结石的随机试验。
J Urol. 1988 Aug;140(2):318-24. doi: 10.1016/s0022-5347(17)41592-8.
7
Effect of acetohydroxamic acid on dissolution of canine struvite uroliths.乙酰氧肟酸对犬鸟粪石尿石溶解的影响。
Am J Vet Res. 1984 Jul;45(7):1266-75.
8
Struvite crystal formation by Corynebacterium group D2 in human urine and its prevention by acetohydroxamic acid.D2 群棒状杆菌在人尿中形成鸟粪石晶体及其被乙酰氧肟酸预防的情况。
Eur Urol. 1987;13(4):271-3. doi: 10.1159/000472793.
9
Adjunctive chemotherapy of infection-induced staghorn calculi.感染性鹿角形结石的辅助化疗
Trans Am Assoc Genitourin Surg. 1978;70:25-9.
10
New treatment for struvite urinary stones.
N Engl J Med. 1984 Sep 20;311(12):792-4. doi: 10.1056/NEJM198409203111210.

引用本文的文献

1
Effect of long-term postoperative OM-89 administration on bacteriuria from suspected infectious stones.术后长期服用OM-89对疑似感染性结石所致菌尿的影响。
Investig Clin Urol. 2025 May;66(3):261-271. doi: 10.4111/icu.20250086.
2
Dissolution of struvite stones with ascorbic acid.用抗坏血酸溶解鸟粪石结石。
Urol Case Rep. 2024 Dec 10;58:102906. doi: 10.1016/j.eucr.2024.102906. eCollection 2025 Jan.
3
Targeting bacterial nickel transport with aspergillomarasmine A suppresses virulence-associated Ni-dependent enzymes.靶向细菌镍转运体抑制与致病性相关的 Ni 依赖性酶的 Aspergillomarasmine A。
Nat Commun. 2024 May 13;15(1):4036. doi: 10.1038/s41467-024-48232-1.
4
Follow-up of urolithiasis patients after treatment: an algorithm from the EAU Urolithiasis Panel.尿路结石患者治疗后的随访:欧洲泌尿外科学会尿路结石专家组的一项算法
World J Urol. 2024 Mar 28;42(1):202. doi: 10.1007/s00345-024-04872-y.
5
The Saudi urological association guidelines on urolithiasis.沙特泌尿外科协会尿路结石指南。
Urol Ann. 2024 Jan-Mar;16(1):1-27. doi: 10.4103/ua.ua_120_23. Epub 2024 Jan 25.
6
-acetylcysteine prevents catheter occlusion and inflammation in catheter associated-urinary tract infections by suppressing urease activity.乙酰半胱氨酸通过抑制脲酶活性预防导管相关性尿路感染中的导管阻塞和炎症。
Front Cell Infect Microbiol. 2023 Oct 26;13:1216798. doi: 10.3389/fcimb.2023.1216798. eCollection 2023.
7
The effectiveness of citrates and pyridoxine in the treatment of kidney stones.枸橼酸盐和吡哆醇治疗肾结石的疗效。
J Med Life. 2023 Jun;16(6):856-861. doi: 10.25122/jml-2023-0234.
8
Infection responsive coatings to reduce biofilm formation and encrustation of urinary catheters.抗感染响应涂层减少导尿管生物膜形成和结垢。
J Appl Microbiol. 2023 Jun 1;134(6). doi: 10.1093/jambio/lxad121.
9
International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis.国际尿石症联盟(IAU)尿路结石代谢评估与医学管理指南。
Urolithiasis. 2022 Dec 1;51(1):4. doi: 10.1007/s00240-022-01387-2.
10
AKI in a Patient with Urinary Tract Infection, Urinary Crystals, and a Bladder Stone.一名患有尿路感染、尿路结晶和膀胱结石患者的急性肾损伤
Kidney360. 2022 Mar 3;3(4):790-792. doi: 10.34067/KID.0006112021. eCollection 2022 Apr 28.